Loading…

Carbamazepine and L-type calcium channel inhibitors: A binding assay study

Saved in:

Bibliographic Details
Published in:	Biological psychiatry (1969) 1996-06, Vol.39 (11), p.979-981
Main Authors:	Ngan, Elton T.C., Vincent, Steven R.
Format:	Article
Language:	English
Subjects:	affective disorder Analgesics, Non-Narcotic - pharmacokinetics Animals Anticonvulsants. Antiepileptics. Antiparkinson agents Binding, Competitive - drug effects Biological and medical sciences calcium antagonist Calcium Channel Blockers - pharmacokinetics calcium channels Carbamazepine Carbamazepine - pharmacokinetics dihydropyridine Diltiazem - pharmacokinetics In Vitro Techniques Isradipine - pharmacokinetics Lithium - pharmacology Male Medical sciences Neuropharmacology Pharmacology. Drug treatments Phenethylamines - pharmacokinetics Rats Rats, Wistar verapamil Verapamil - pharmacokinetics
Citations:	Items that this one cites
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites	cdi_FETCH-LOGICAL-c335t-36036c4850daa2025a40f8e280b3ac04a063bd247e2fb983c90444911cfaf25d3
container_end_page	981
container_issue	11
container_start_page	979
container_title	Biological psychiatry (1969)
container_volume	39
creator	Ngan, Elton T.C. Vincent, Steven R.
description
doi_str_mv	10.1016/0006-3223(95)00631-1
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78423575</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006322395006311</els_id><sourcerecordid>78423575</sourcerecordid><originalsourceid>FETCH-LOGICAL-c335t-36036c4850daa2025a40f8e280b3ac04a063bd247e2fb983c90444911cfaf25d3</originalsourceid><addsrcrecordid>eNp9kEtrGzEQgEVocBy3_yABHUppD5vqta8eCsakeWDopT2LWWk2VtjVOtJuwP31lWPjY04zw3wzI32EXHF2wxkvvjPGikwKIb_W-beUS57xMzLnVSkzoZj4QOYn5IJcxvicylIIPiOzmhcpEXPyuILQQA__cOs8UvCWrrNxt0VqoDNu6qnZgPfYUec3rnHjEOIPuqSN89b5Jwoxwo7GcbK7j-S8hS7ip2NckL-_bv-s7rP177uH1XKdGSnzMZMFk4VRVc4sgGAiB8XaCkXFGgmGKUg_aaxQJYq2qStpaqaUqjk3LbQit3JBvhz2bsPwMmEcde-iwa4Dj8MUdVkpIfMyT6A6gCYMMQZs9Ta4HsJOc6b3CvXej9770XWu3xRqnsauj_unpkd7Gjo6S_3Pxz7EJKkN4I2LJ0xywetif_3nAcPk4tVh0NE49AatC2hGbQf3_jv-A4jHiwM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78423575</pqid></control><display><type>article</type><title>Carbamazepine and L-type calcium channel inhibitors: A binding assay study</title><source>ScienceDirect Journals</source><creator>Ngan, Elton T.C. ; Vincent, Steven R.</creator><creatorcontrib>Ngan, Elton T.C. ; Vincent, Steven R.</creatorcontrib><identifier>ISSN: 0006-3223</identifier><identifier>EISSN: 1873-2402</identifier><identifier>DOI: 10.1016/0006-3223(95)00631-1</identifier><identifier>PMID: 9162212</identifier><identifier>CODEN: BIPCBF</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>affective disorder ; Analgesics, Non-Narcotic - pharmacokinetics ; Animals ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Binding, Competitive - drug effects ; Biological and medical sciences ; calcium antagonist ; Calcium Channel Blockers - pharmacokinetics ; calcium channels ; Carbamazepine ; Carbamazepine - pharmacokinetics ; dihydropyridine ; Diltiazem - pharmacokinetics ; In Vitro Techniques ; Isradipine - pharmacokinetics ; Lithium - pharmacology ; Male ; Medical sciences ; Neuropharmacology ; Pharmacology. Drug treatments ; Phenethylamines - pharmacokinetics ; Rats ; Rats, Wistar ; verapamil ; Verapamil - pharmacokinetics</subject><ispartof>Biological psychiatry (1969), 1996-06, Vol.39 (11), p.979-981</ispartof><rights>1996 Society of Biological Psychiatry</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c335t-36036c4850daa2025a40f8e280b3ac04a063bd247e2fb983c90444911cfaf25d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3121965$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9162212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ngan, Elton T.C.</creatorcontrib><creatorcontrib>Vincent, Steven R.</creatorcontrib><title>Carbamazepine and L-type calcium channel inhibitors: A binding assay study</title><title>Biological psychiatry (1969)</title><addtitle>Biol Psychiatry</addtitle><subject>affective disorder</subject><subject>Analgesics, Non-Narcotic - pharmacokinetics</subject><subject>Animals</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Binding, Competitive - drug effects</subject><subject>Biological and medical sciences</subject><subject>calcium antagonist</subject><subject>Calcium Channel Blockers - pharmacokinetics</subject><subject>calcium channels</subject><subject>Carbamazepine</subject><subject>Carbamazepine - pharmacokinetics</subject><subject>dihydropyridine</subject><subject>Diltiazem - pharmacokinetics</subject><subject>In Vitro Techniques</subject><subject>Isradipine - pharmacokinetics</subject><subject>Lithium - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenethylamines - pharmacokinetics</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>verapamil</subject><subject>Verapamil - pharmacokinetics</subject><issn>0006-3223</issn><issn>1873-2402</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNp9kEtrGzEQgEVocBy3_yABHUppD5vqta8eCsakeWDopT2LWWk2VtjVOtJuwP31lWPjY04zw3wzI32EXHF2wxkvvjPGikwKIb_W-beUS57xMzLnVSkzoZj4QOYn5IJcxvicylIIPiOzmhcpEXPyuILQQA__cOs8UvCWrrNxt0VqoDNu6qnZgPfYUec3rnHjEOIPuqSN89b5Jwoxwo7GcbK7j-S8hS7ip2NckL-_bv-s7rP177uH1XKdGSnzMZMFk4VRVc4sgGAiB8XaCkXFGgmGKUg_aaxQJYq2qStpaqaUqjk3LbQit3JBvhz2bsPwMmEcde-iwa4Dj8MUdVkpIfMyT6A6gCYMMQZs9Ta4HsJOc6b3CvXej9770XWu3xRqnsauj_unpkd7Gjo6S_3Pxz7EJKkN4I2LJ0xywetif_3nAcPk4tVh0NE49AatC2hGbQf3_jv-A4jHiwM</recordid><startdate>19960601</startdate><enddate>19960601</enddate><creator>Ngan, Elton T.C.</creator><creator>Vincent, Steven R.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960601</creationdate><title>Carbamazepine and L-type calcium channel inhibitors: A binding assay study</title><author>Ngan, Elton T.C. ; Vincent, Steven R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c335t-36036c4850daa2025a40f8e280b3ac04a063bd247e2fb983c90444911cfaf25d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>affective disorder</topic><topic>Analgesics, Non-Narcotic - pharmacokinetics</topic><topic>Animals</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Binding, Competitive - drug effects</topic><topic>Biological and medical sciences</topic><topic>calcium antagonist</topic><topic>Calcium Channel Blockers - pharmacokinetics</topic><topic>calcium channels</topic><topic>Carbamazepine</topic><topic>Carbamazepine - pharmacokinetics</topic><topic>dihydropyridine</topic><topic>Diltiazem - pharmacokinetics</topic><topic>In Vitro Techniques</topic><topic>Isradipine - pharmacokinetics</topic><topic>Lithium - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenethylamines - pharmacokinetics</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>verapamil</topic><topic>Verapamil - pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ngan, Elton T.C.</creatorcontrib><creatorcontrib>Vincent, Steven R.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biological psychiatry (1969)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ngan, Elton T.C.</au><au>Vincent, Steven R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbamazepine and L-type calcium channel inhibitors: A binding assay study</atitle><jtitle>Biological psychiatry (1969)</jtitle><addtitle>Biol Psychiatry</addtitle><date>1996-06-01</date><risdate>1996</risdate><volume>39</volume><issue>11</issue><spage>979</spage><epage>981</epage><pages>979-981</pages><issn>0006-3223</issn><eissn>1873-2402</eissn><coden>BIPCBF</coden><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>9162212</pmid><doi>10.1016/0006-3223(95)00631-1</doi><tpages>3</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0006-3223
ispartof	Biological psychiatry (1969), 1996-06, Vol.39 (11), p.979-981
issn	0006-3223 1873-2402
language	eng
recordid	cdi_proquest_miscellaneous_78423575
source	ScienceDirect Journals
subjects	affective disorder Analgesics, Non-Narcotic - pharmacokinetics Animals Anticonvulsants. Antiepileptics. Antiparkinson agents Binding, Competitive - drug effects Biological and medical sciences calcium antagonist Calcium Channel Blockers - pharmacokinetics calcium channels Carbamazepine Carbamazepine - pharmacokinetics dihydropyridine Diltiazem - pharmacokinetics In Vitro Techniques Isradipine - pharmacokinetics Lithium - pharmacology Male Medical sciences Neuropharmacology Pharmacology. Drug treatments Phenethylamines - pharmacokinetics Rats Rats, Wistar verapamil Verapamil - pharmacokinetics
title	Carbamazepine and L-type calcium channel inhibitors: A binding assay study
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A42%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbamazepine%20and%20L-type%20calcium%20channel%20inhibitors:%20A%20binding%20assay%20study&rft.jtitle=Biological%20psychiatry%20(1969)&rft.au=Ngan,%20Elton%20T.C.&rft.date=1996-06-01&rft.volume=39&rft.issue=11&rft.spage=979&rft.epage=981&rft.pages=979-981&rft.issn=0006-3223&rft.eissn=1873-2402&rft.coden=BIPCBF&rft_id=info:doi/10.1016/0006-3223(95)00631-1&rft_dat=%3Cproquest_cross%3E78423575%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c335t-36036c4850daa2025a40f8e280b3ac04a063bd247e2fb983c90444911cfaf25d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78423575&rft_id=info:pmid/9162212&rfr_iscdi=true